| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_923e5e1b1a49544c1c90da2465e91e83
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd1b4a1735763aaf0363469766440620
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ab0c2d30e6346ca282dd7dca4129f779 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 |
| filingDate |
2007-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ccec67d049d157b52988d2b91afbe33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9bf68ff8ed1ce85e86acc2e8efc0ef44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7272cf679a27ba263e579d12507940e4 |
| publicationDate |
2008-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2007140200-A3 |
| titleOfInvention |
Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors |
| abstract |
The invention encompasses compounds of formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7977331-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7659263-B2 |
| priorityDate |
2006-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |